Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Bayer, CV Therapeutics collaborate on antiinflammatory drugs

May 24, 1996

Canadian health authorities commission LifeTECH labs

May 17, 1996

Xytronyx in-licenses LSAI technology

May 17, 1996

ArQule's AMAP system receives patent coverage

May 17, 1996

Three-way collaboration in cardiovascular field announced

May 17, 1996

Symbollon, Oclassen to codevelop dermatology products

May 17, 1996

Neuroprotective compounds target of new research agreement

May 17, 1996

Gensia, Pfizer to collaborate on ARA-based analgesics

May 17, 1996

Dyax phage display technology receives patent protection

May 10, 1996

CEPRATE SC approvable for autologous BMT

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...